Tateo V, Basile G, Giannatempo P, de Jong JJ, et al. Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. Eur Urol 2026 Feb 2:S0302-2838(26)00022-9. doi: 10.1016/j.eururo.2026.
PMID: 41633898